Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v2.4.0.8
Condensed Balance Sheets (USD $)
May 31, 2013
Nov. 30, 2012
Current Assets    
Cash and cash equivalents $ 6,498   
Total Current Assets 6,498  
TOTAL ASSETS 6,498  
Current Liabilities    
Accrued liabilities 1,000  
TOTAL LIABILITIES 1,000  
COMMITMENTS AND CONTINGENCIES (NOTE 7)      
STOCKHOLDERS' EQUITY    
Preferred stock, 15,000,000 shares authorized; par value $0.0001, none issued and outstanding      
Common Stock, 100,000,000 shares authorized; par value $0.0001, 4,050,000 and 950,000 shares issued and outstanding, respectively 405 95
Additional paid-in capital 19,795 855
Accumulated deficit during development stage (14,702) (950)
Total Stockholders' Equity 5,498   
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 6,498